The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes is a research paper published in Cells (2020). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: EY025383, EY012601, EY028858, EY028037 and NS102415
NEI NIH HHS
Grant: R01 EY028858
NEI NIH HHS
Grant: R01 EY012601
NEI NIH HHS
Grant: R01 EY025383
NEI NIH HHS
Grant: P30 EY003039
NIDDK NIH HHS
Grant: P30 DK079626
NINDS NIH HHS
Grant: R01 NS102415
National Institutes of Health
Grant: 5R01EY025383-04
LXR as a Novel Therapeutic Target in Diabetic Retinopathy
National Institutes of Health
Grant: 5R01EY012601-09
Endothelial precursor dysfunction in development of diabetic acellular capillary
National Institutes of Health
Grant: 5R01EY028858-03
ACE2 Modulates the Bone Marrow- Gut Axis in Diabetic Retinopathy
National Institutes of Health
Grant: 5R01NS102415-03
The role of cell-specific TLR-4 signaling in oxaliplatin-induced peripheral neuropathy
National Institutes of Health
Grant: 5R01EY028037-04
Somatostatin blockade of CNS autonomic hyperactivity for treatment of diabetic retinopathy
FWCI
3.63
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals